Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|August 19, 1992
Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitroE M Hersh, C R Gschwind, C W Taylor, et al.
Cancer Treatment Reviews|January 1, 1993
High-dose carboplatin chemotherapy with GM-CSF and peripheral blood progenitor cell support: a model for delivering repeated cycles of dose-intensive therapyT C Shea, J R Mason, A M Storniolo, et al.
Genes, Chromosomes & Cancer|April 30, 1999
Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 casesR Taetle, M Aickin, L Panda, et al.
Seminars in Oncology|February 1, 1992
A dose-escalation study of carboplatin/cyclophosphamide/etoposide along with autologous bone marrow or peripheral blood stem cell rescueT C Shea, A M Storniolo, J R Mason, et al.
Cancer Genetics and Cytogenetics|December 9, 1998
Detection of chromosome 6 abnormalities in melanoma cell lines by chromosome arm painting probesX Y Guan, H Zhang, J M Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6D Brooks, C Taylor, B Dos Santos, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Characterization of cellular accumulation and toxicity of illudin S in sensitive and nonsensitive tumor cellsM J Kelner, T C McMorris, M A Montoya, et al.
Genes, Chromosomes & Cancer|August 1, 1994
Simple numeric abnormalities as primary karyotype changes in ovarian carcinomaF H Thompson, Y Liu, J Emerson, et al.
Cancer Research|November 1, 1995
Efficacy of Acylfulvene Illudin analogues against a metastatic lung carcinoma MV522 xenograft nonresponsive to traditional anticancer agents: retention of activity against various mdr phenotypes and unusual cytotoxicity against ERCC2 and ERCC3 DNA helicase-deficient cellsM J Kelner, T C McMorris, L Estes, et al.
British Journal of Haematology|November 1, 1996
Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancyP J Kling, P R Dragsten, R A Roberts, et al.
Pageof 12